{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Raynham",
      "address_1": "325 Paramount Drive",
      "reason_for_recall": "A small number of specific pumps may trigger a low battery alarm at the beginning of the implanted life.",
      "address_2": "",
      "product_quantity": "90",
      "code_info": "Serial Numbers: NNBLTL, NNBLT5, NNBLR9, NNBLT2, NNBLJP, NNBLL2, NNBLJR, NNBLLH, NNBLLJ, NNBLLG, NNBLT0, NNBLT1, NNBLL7, NNBLTC, NNBLTN, NNBLTK, NPBLZ7, NPBLZH, NPBLZP, NPBLZN, NPBLZM, NPBLZK, NPBLZ4, NPBLZJ, NPBLY3, NPBLY5, NPBLY4, NPBLY7, NPBLZT, NPBLY9, NPBLZR, NPBL7M, NPBL74, NPBMFN, NPBMF0, NPBMHJ, NPBMHK, NPBL71  NPBL9H, NNBLLP, NNBLLN, NNBLLC, NNBLLD, NNBLL3, NPBL0F, NNBLTH,   NPBL6N, NPBL6M, NPBL6L, NPBL1T, NPBL17, NPBL1Y, NPBL1W, NPBL75,   NPBL70, NPBL76, NNBLG2, NPBMFG, NPBMF4, NPBMF2, NPBMF1, NPBMF5,   NPBMH2, NPBMH0, NNBLJM, NNBLJK, NNBLJN, NNBLHZ, NNBLHW, NNBLH2, NNBLH1, NNBLH0, NNBLTB, NNBLL4, NPBL1R, NPBL1P, NPBL1N,   NPBL1L, NPBL1J, NPBL9N, NPBL9K, NPBL9L, NNBLHN, NNBLGV, NNBLHT,   NNBLHM, NNBLG0, NNBLLK, NMBKBW, NMBJ5G",
      "center_classification_date": "20140509",
      "distribution_pattern": "Worldwide Distribution including the countries of Belgium Germany, Spain,  United Kingdom,  Ireland,  Italy,  Russia and Turkey.",
      "state": "MA",
      "product_description": "MedStream Programmable Infusion Pump, 20 mL, Product Code: 91-4200    The MedStream programmable pump is intended for the intrathecal delivery of Baclofen in the US market and for the intrathecal delivery of Morphine or Baclofen in the EMEA market.",
      "report_date": "20140521",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Codman & Shurtleff, Inc.",
      "recall_number": "Z-1571-2014",
      "initial_firm_notification": "Letter",
      "product_type": "Devices",
      "event_id": "67921",
      "termination_date": "20151110",
      "more_code_info": "",
      "recall_initiation_date": "20151110",
      "postal_code": "02767",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}